PSI Advisors’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-650
| Closed | -$3.74K | – | 131 |
|
|
2025
Q1 | $3.74K | Hold |
650
| – | – | ﹤0.01% | 551 |
|
|
2024
Q4 | $3.24K | Hold |
650
| – | – | ﹤0.01% | 675 |
|
|
2024
Q3 | $3.5K | Hold |
650
| – | – | ﹤0.01% | 701 |
|
|
2024
Q2 | $2.15K | Hold |
650
| – | – | ﹤0.01% | 710 |
|
|
2024
Q1 | $2.13K | Hold |
650
| – | – | ﹤0.01% | 664 |
|
|
2023
Q4 | $2.28K | Buy |
650
+150
| +30% | +$527 | ﹤0.01% | 707 |
|
|
2023
Q3 | $3.34K | Hold |
500
| – | – | ﹤0.01% | 639 |
|
|
2023
Q2 | $4.2K | Hold |
500
| – | – | ﹤0.01% | 603 |
|
|
2023
Q1 | $4.97K | Hold |
500
| – | – | ﹤0.01% | 534 |
|
|
2022
Q4 | $3.48K | Hold |
500
| – | – | ﹤0.01% | 558 |
|
|
2022
Q3 | $3K | Hold |
500
| – | – | ﹤0.01% | 578 |
|
|
2022
Q2 | $2K | Hold |
500
| – | – | ﹤0.01% | 652 |
|
|
2022
Q1 | $2K | Hold |
500
| – | – | ﹤0.01% | 610 |
|
|
2021
Q4 | $2K | Hold |
500
| – | – | ﹤0.01% | 651 |
|
|
2021
Q3 | $4K | Buy |
+500
| New | +$4K | ﹤0.01% | 591 |
|